1. Home
  2. TECH vs CRL Comparison

TECH vs CRL Comparison

Compare TECH & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TECH
  • CRL
  • Stock Information
  • Founded
  • TECH 1976
  • CRL 1947
  • Country
  • TECH United States
  • CRL United States
  • Employees
  • TECH N/A
  • CRL N/A
  • Industry
  • TECH Biotechnology: Biological Products (No Diagnostic Substances)
  • CRL Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • TECH Health Care
  • CRL Health Care
  • Exchange
  • TECH Nasdaq
  • CRL Nasdaq
  • Market Cap
  • TECH 7.8B
  • CRL 7.1B
  • IPO Year
  • TECH 1989
  • CRL 2000
  • Fundamental
  • Price
  • TECH $53.94
  • CRL $159.42
  • Analyst Decision
  • TECH Buy
  • CRL Buy
  • Analyst Count
  • TECH 12
  • CRL 14
  • Target Price
  • TECH $70.00
  • CRL $184.85
  • AVG Volume (30 Days)
  • TECH 1.9M
  • CRL 818.3K
  • Earning Date
  • TECH 08-06-2025
  • CRL 08-06-2025
  • Dividend Yield
  • TECH 0.59%
  • CRL N/A
  • EPS Growth
  • TECH N/A
  • CRL N/A
  • EPS
  • TECH 0.83
  • CRL N/A
  • Revenue
  • TECH $1,208,770,000.00
  • CRL $4,022,597,000.00
  • Revenue This Year
  • TECH $7.07
  • CRL N/A
  • Revenue Next Year
  • TECH $5.72
  • CRL $2.49
  • P/E Ratio
  • TECH $65.29
  • CRL N/A
  • Revenue Growth
  • TECH 4.72
  • CRL N/A
  • 52 Week Low
  • TECH $46.01
  • CRL $91.86
  • 52 Week High
  • TECH $83.62
  • CRL $254.15
  • Technical
  • Relative Strength Index (RSI)
  • TECH 59.94
  • CRL 62.71
  • Support Level
  • TECH $50.97
  • CRL $152.73
  • Resistance Level
  • TECH $55.53
  • CRL $168.12
  • Average True Range (ATR)
  • TECH 2.07
  • CRL 5.21
  • MACD
  • TECH 0.24
  • CRL 0.49
  • Stochastic Oscillator
  • TECH 77.60
  • CRL 63.37

About TECH Bio-Techne Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Share on Social Networks: